Multiple dietary supplements do not affect metabolic and cardiovascular health

Aging

Volumn 6, Issue 2, 2014, Pages 149-157

  Soare, Andreea ^a,b   Weiss, Edward P ^a,c   Holloszy, John O ^a   Fontana, Luigi ^a,d,e  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c SAINT LOUIS UNIVERSITY   (United States)

^d UNIVERSITY OF SALERNO   (Italy)

^e CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

Arterial stiffness; Endothelial function; Inflammation; Oxidative stress; Supplements

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HUMAN; MALE; METABOLIC DISORDER; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ADULT; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MALE; METABOLIC DISEASES; MIDDLE AGED;

EID: 84897827313     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100597     Document Type: Article

References (39)

1. Blendon RJ, Benson JM, Botta MD, Weldon KJ. Users' views of dietary supplements. JAMA Intern Med 2013; 173:74-6.
2. Denham BE. Dietary supplements--regulatory issues and implications for public health. JAMA 2011; 306:428-9.
3. Almeida IM, Barreira JC, Oliveira MB, Ferreira IC. Dietary antioxidant supplements: benefits of their combined use. Food Chem Toxicol 2011; 49:3232-7.
4. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nature reviews. Drug discovery. 2006; 5:493- 506.
5. Das S, Das DK. Anti-inflammatory responses of resveratrol. Inflammation & allergy drug targets. 2007; 6:168-173.
6. Chan MM. Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem. Pharmacol. 1995; 49:1551-1556.
7. Ruby AJ, Kuttan G, Babu KD, Rajasekharan KN, Kuttan R. Antitumour and antioxidant activity of natural curcuminoids. Cancer Lett. 1995; 94:79-83.
8. Balentine D, Paetau-Robinson I. Tea as a source of dietary antioxidants with a potential role in prevention of chronic diseases. In: Mazza G, BD O, eds. Herbs, Botanicals & Teas. Lancaster: Technomic Publishing Co., Inc.; 2000:265-287.
9. Aneja R, Odoms K, Denenberg AG, Wong HR. Theaflavin, a black tea extract, is a novel anti-inflammatory compound. Crit. Care Med. 2004; 32:2097-2103.
10. Bors W, Heller W, Michel C, Saran M. Flavonoids as antioxidants: determination of radical-scavenging efficiencies. Methods Enzymol. 1990; 186:343-355.
11. García-Mediavilla V, Crespo I, Collado PS, Esteller A, Sánchez-Campos S, Tuñón MJ, González-Gallego J. The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang Liver cells. Eur. J. Pharmacol. 2007; 557:221-229.
12. Mackraj I, Govender T, Ramesar S. The antihypertensive effects of quercetin in a salt-sensitive model of hypertension. J. Cardiovasc. Pharmacol. 2008; 51:239-245.
13. Rivera L, Moron R, Sanchez M, Zarzuelo A, Galisteo M. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity. 2008; 16:2081-2087.
14. Hagen TM, Liu J, Lykkesfeldt J, Wehr CM, Ingersoll RT, Vinarsky V, Bartholomew JC, Ames BN. Feeding acetyl-Lcarnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 2002; 99:1870-1875.
15. Aviram M, Dornfeld L, Rosenblat M, Volkova N, Kaplan M, Coleman R, Hayek T, Presser D, Fuhrman B. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am. J. Clin. Nutr. 2000; 71:1062-1076.
16. Aviram M, Dornfeld L. Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis. 2001; 158:195-198.
17. Lin CC, Wu SJ, Chang CH, Ng LT. Antioxidant activity of Cinnamomum cassia. Phytother. Res. 2003; 17:726-730.
18. Reddy AM, Seo JH, Ryu SY, Kim YS, Min KR. Cinnamaldehyde and 2 methoxycinnamaldehyde as NF-kappaB inhibitors from Cinnamomum cassia. Planta Med. 2004; 70:823-827.
19. Qin B, Nagasaki M, Ren M, Bajotto G, Oshida Y, Sato Y. Cinnamon extract (traditional herb) potentiates in vivo insulinregulated glucose utilization via enhancing insulin signaling in rats. Diabetes Res. Clin. Pract. 2003; 62:139-148.
20. Qin B, Nagasaki M, Ren M, Bajotto G, Oshida Y, Sato Y. Cinnamon extract prevents the insulin resistance induced by a high-fructose diet. Horm. Metab. Res. 2004; 36:119-125.
21. Ashakumary L, Rouyer I, Takahashi Y, Ide T, Fukuda N, Aoyama T, Hashimoto T, Mizugaki M, Sugano M. Sesamin, a sesame lignan, is a potent inducer of hepatic fatty acid oxidation in the rat. Metabolism. 1999; 48:1303-1313.
22. Arachchige PG, Takahashi Y, Ide T. Dietary sesamin and docosahexaenoic and eicosapentaenoic acids synergistically increase the gene expression of enzymes involved in hepatic peroxisomal fatty acid oxidation in rats. Metabolism. 2006; 55:381-390.
23. Hirose N, Inoue T, Nishihara K, Sugano M, Akimoto K, Shimizu S and Yamada H. Inhibition of cholesterol absorption and synthesis in rats by sesamin. J. Lipid Res. 1991; 32:629-638.
24. Calder PC. Polyunsaturated fatty acids, inflammation, and immunity. Lipids. 2001; 36:1007-1024.
25. Noma K, Goto C, Nishioka K, Jitsuiki D, Umemura T, Ueda K, Kimura M, Nakagawa K, Oshima T, Chayama K, Yoshizumi M, Liao JK, Higashi Y. Roles of rho-associated kinase and oxidative stress in the pathogenesis of aortic stiffness. J Am Coll Cardiol. 2007; 49:698-705.
26. Abramson JL, Weintraub WS and Vaccarino V. Association between pulse pressure and C-reactive protein among apparently healthy US adults. Hypertension 2002; 39: 197-202.
27. Mattace-Raso FUS, van der Cammen TJM, van der Meer IM, Schalekamp MADH, Asmar R, Hofman A and Witteman JCM. Creactive protein and arterial stiffness in older adults: The Rotterdam Study. Atherosclerosis 2004; 176: 111-116.
28. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004; 109:III27-32.
29. Hürlimann D, Forster A, Noll G, Enseleit F, Chenevard R, Distler O, Béchir M, Spieker LE, Neidhart M, Michel BA, Gay RE, Lüscher TF, Gay S, Ruschitzka F. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 2002; 106:2184-7.
30. Eskurza I, Monahan KD, Robinson JA, Seals DR. Effect of acute and chronic ascorbic acid on flow-mediated dilatation with sedentary and physically active human ageing. J Physiol 2004; 556:315-24.
31. Weiss EP, Villareal DT, Ehsani AA, Fontana L, Holloszy JO. Dehydroepiandrosterone replacement therapy in older adults improves indices of arterial stiffness. Aging Cell 2012; 11: 876- 84.
32. Williamson G, Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 2005; 81:243-55.
33. Office UGA. Herbal dietary supplements: examples of deceptive or questionable marketing practices and potentially dangerous advice. Publication No GAO-10-662T. http://www.gao.gov/new.items/d10662t.pdf (12 August 2013).
34. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H; European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical application. Eur Heart J 2006; 27:2588-2605.
35. Wilkinson IB, Mohammad NH, Tyrrell S, Hall IR, Webb DJ, Paul VE, Levy T, Cockcroft JR. Heart rate dependency of pulse pressure amplification and arterial stiffness. Am J Hypertens 2002; 15:24-30.
36. Karamanoglu M. Errors in estimating propagation distance in pulse wave velocity. Hypertension 2003; 41:e8.
37. Sidhu JS, Newey VR, Nassiri DK, Kaski JC. A rapid and reproducible on line automated technique to determine endothelial function. Heart 2002; 88:289-92.
38. Fontana L, Meyer TE, Klein S, Holloszy JO. Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc Natl Acad Sci USA 2004; 101:6659-63.
39. Fontana L, Villareal DT, Weiss EP, Racette SB, Steger-May K, Klein S, Holloszy JO; Washington University School of Medicine CALERIE Group.Calorie restriction or exercise: effects on coronary heart disease risk factors. A randomized, controlled trial. Am J Physiol Endocrinol Metab 2007; 293:197-202.